<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">18824496</PMID><DateCompleted><Year>2009</Year><Month>01</Month><Day>30</Day></DateCompleted><DateRevised><Year>2022</Year><Month>01</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1460-2083</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>1</Issue><PubDate><Year>2009</Year><Month>Jan</Month><Day>01</Day></PubDate></JournalIssue><Title>Human molecular genetics</Title><ISOAbbreviation>Hum Mol Genet</ISOAbbreviation></Journal><ArticleTitle>Mitochondrial abnormalities in spinal and bulbar muscular atrophy.</ArticleTitle><Pagination><StartPage>27</StartPage><EndPage>42</EndPage><MedlinePgn>27-42</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/hmg/ddn310</ELocationID><Abstract><AbstractText>Spinal and bulbar muscular atrophy (SBMA) is a motor neuron disease caused by polyglutamine expansion mutation in the androgen receptor (AR). We investigated whether the mutant protein alters mitochondrial function. We found that constitutive and doxycycline-induced expression of the mutant AR in MN-1 and PC12 cells, respectively, are associated with depolarization of the mitochondrial membrane. This was mitigated by cyclosporine A, which inhibits opening of the mitochondrial permeability transition pore. We also found that the expression of the mutant protein in the presence of ligand results in an elevated level of reactive oxygen species, which is blocked by the treatment with the antioxidants co-enzyme Q10 and idebenone. The mutant protein in MN-1 cells also resulted in increased Bax, caspase 9 and caspase 3. We assessed the effects of mutant AR on the transcription of mitochondrial proteins and found altered expression of the peroxisome proliferator-activated receptor gamma coactivator 1 and the mitochondrial specific antioxidant superoxide dismutase-2 in affected tissues of SBMA knock-in mice. In addition, we found that the AR associates with mitochondria in cultured cells. This study thus provides evidence for mitochondrial dysfunction in SBMA cell and animal models, either through indirect effects on the transcription of nuclear-encoded mitochondrial genes or through direct effects of the mutant protein on mitochondria or both. These findings indicate possible benefit from mitochondrial therapy for SBMA.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ranganathan</LastName><ForeName>Srikanth</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, Bethesda, MD, USA. ranganas@ninds.nih.gov</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harmison</LastName><ForeName>George G</ForeName><Initials>GG</Initials></Author><Author ValidYN="Y"><LastName>Meyertholen</LastName><ForeName>Kristin</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Pennuto</LastName><ForeName>Maria</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Burnett</LastName><ForeName>Barrington G</ForeName><Initials>BG</Initials></Author><Author ValidYN="Y"><LastName>Fischbeck</LastName><ForeName>Kenneth H</ForeName><Initials>KH</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>GFP04005</GrantID><Acronym>TI_</Acronym><Agency>Telethon</Agency><Country>Italy</Country></Grant><Grant><Acronym>ImNIH</Acronym><Agency>Intramural NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052060">Research Support, N.I.H., Intramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2008</Year><Month>09</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Hum Mol Genet</MedlineTA><NlmUniqueID>9208958</NlmUniqueID><ISSNLinking>0964-6906</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017382">Reactive Oxygen Species</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011944">Receptors, Androgen</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.-</RegistryNumber><NameOfSubstance UI="D020169">Caspases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055534" MajorTopicYN="N">Bulbo-Spinal Atrophy, X-Linked</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020169" MajorTopicYN="N">Caspases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016923" MajorTopicYN="N">Cell Death</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015870" MajorTopicYN="N">Gene Expression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053078" MajorTopicYN="N">Membrane Potential, Mitochondrial</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008928" MajorTopicYN="N">Mitochondria</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017382" MajorTopicYN="N">Reactive Oxygen Species</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011944" MajorTopicYN="N">Receptors, Androgen</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2008</Year><Month>10</Month><Day>1</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2008</Year><Month>10</Month><Day>1</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2009</Year><Month>1</Month><Day>31</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">18824496</ArticleId><ArticleId IdType="pmc">PMC2644643</ArticleId><ArticleId IdType="doi">10.1093/hmg/ddn310</ArticleId><ArticleId IdType="pii">ddn310</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>La Spada A.R., Wilson E.M., Lubahn D.B., Harding A.E., Fischbeck K.H. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature. 1991;352:77&#x2013;79.</Citation><ArticleIdList><ArticleId IdType="pubmed">2062380</ArticleId></ArticleIdList></Reference><Reference><Citation>Orr H.T., Zoghbi H.Y. Trinucleotide repeat disorders. Ann. Rev. Neurosci. 2007;30:575&#x2013;621.</Citation><ArticleIdList><ArticleId IdType="pubmed">17417937</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsuno M., Adachi H., Waza M., Banno H., Suzuki K., Tanaka F., Doyu M., Sobue G. Pathogenesis, animal models and therapeutics in spinal and bulbar muscular atrophy (SBMA) Exp. Neurol. 2006;200:8&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pubmed">16513111</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks B.P., Fischbeck K.H. Spinal and bulbar muscular atrophy: a trinucleotide-repeat expansion neurodegenerative disease. Trends Neurosci. 1995;18:459&#x2013;461.</Citation><ArticleIdList><ArticleId IdType="pubmed">8545913</ArticleId></ArticleIdList></Reference><Reference><Citation>Wieacker P.F., Knoke I., Jakubiczka S. Clinical and molecular aspects of androgen receptor defects. Exp. Clin. Endocrinol. Diabetes. 1998;106:446&#x2013;453.</Citation><ArticleIdList><ArticleId IdType="pubmed">10079022</ArticleId></ArticleIdList></Reference><Reference><Citation>Poletti A., Negri-Cesi P., Martini L. Reflections on the diseases linked to mutations of the androgen receptor. Endocrine. 2005;28:243&#x2013;262.</Citation><ArticleIdList><ArticleId IdType="pubmed">16388114</ArticleId></ArticleIdList></Reference><Reference><Citation>Palazzolo I., Gliozzi A., Rusmini P., Sau D., Crippa V., Simonini F., Onesto E., Bolzoni E., Poletti A. The role of the polyglutamine tract in androgen receptor. J. Steroid Biochem. Mol. Biol. 2008;108:245&#x2013;253.</Citation><ArticleIdList><ArticleId IdType="pubmed">17945479</ArticleId></ArticleIdList></Reference><Reference><Citation>Adachi H., Waza M., Katsuno M., Tanaka F., Doyu M., Sobue G. Pathogenesis and molecular targeted therapy of spinal and bulbar muscular atrophy. Neuropathol. Appl. Neurobiol. 2007;33:135&#x2013;151.</Citation><ArticleIdList><ArticleId IdType="pubmed">17359355</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor J.P., Taye A.A., Campbell C., Kazemi-Esfarjani P., Fischbeck K.H., Min K.T. Aberrant histone acetylation, altered transcription, and retinal degeneration in a Drosophila model of polyglutamine disease are rescued by CREB-binding protein. Genes Dev. 2003;17:1463&#x2013;1468.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC196076</ArticleId><ArticleId IdType="pubmed">12815067</ArticleId></ArticleIdList></Reference><Reference><Citation>McCampbell A., Taylor J.P., Taye A.A., Robitschek J., Li M., Walcott J., Merry D., Chai Y., Paulson H., Sobue G., et al. CREB-binding protein sequestration by expanded polyglutamine. Hum. Mol. Genet. 2000;9:2197&#x2013;2202.</Citation><ArticleIdList><ArticleId IdType="pubmed">10958659</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsuno M., Adachi H., Tanaka F., Sobue G. Spinal and bulbar muscular atrophy: ligand-dependent pathogenesis and therapeutic perspectives. J. Mol. Med. 2004;82:298&#x2013;307.</Citation><ArticleIdList><ArticleId IdType="pubmed">15133611</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsuno M., Adachi H., Doyu M., Minamiyama M., Sang C., Kobayashi Y., Inukai A., Sobue G. Leuprorelin rescues polyglutamine-dependent phenotypes in a transgenic mouse model of spinal and bulbar muscular atrophy. Nat. Med. 2003;9:768&#x2013;773.</Citation><ArticleIdList><ArticleId IdType="pubmed">12754502</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsuno M., Adachi H., Kume A., Li M., Nakagomi Y., Niwa H., Sang C., Kobayashi Y., Doyu M., Sobue G. Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy. Neuron. 2002;35:843&#x2013;854.</Citation><ArticleIdList><ArticleId IdType="pubmed">12372280</ArticleId></ArticleIdList></Reference><Reference><Citation>Chevalier-Larsen E.S., O'Brien C.J., Wang H., Jenkins S.C., Holder L., Lieberman A.P., Merry D.E. Castration restores function and neurofilament alterations of aged symptomatic males in a transgenic mouse model of spinal and bulbar muscular atrophy. J. Neurosci. 2004;24:4778&#x2013;4786.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6729468</ArticleId><ArticleId IdType="pubmed">15152038</ArticleId></ArticleIdList></Reference><Reference><Citation>Walcott J.L., Merry D.E. Ligand promotes intranuclear inclusions in a novel cell model of spinal and bulbar muscular atrophy. J. Biol. Chem. 2002;277:50855&#x2013;50859.</Citation><ArticleIdList><ArticleId IdType="pubmed">12388541</ArticleId></ArticleIdList></Reference><Reference><Citation>Trushina E., McMurray C.T. Oxidative stress and mitochondrial dysfunction in neurodegenerative diseases. Neuroscience. 2007;145:1233&#x2013;1248.</Citation><ArticleIdList><ArticleId IdType="pubmed">17303344</ArticleId></ArticleIdList></Reference><Reference><Citation>Seong I.S., Ivanova E., Lee J.M., Choo Y.S., Fossale E., Anderson M., Gusella J.F., Laramie J.M., Myers R.H., Lesort M., et al. HD CAG repeat implicates a dominant property of huntingtin in mitochondrial energy metabolism. Hum. Mol. Genet. 2005;14:2871&#x2013;2880.</Citation><ArticleIdList><ArticleId IdType="pubmed">16115812</ArticleId></ArticleIdList></Reference><Reference><Citation>Hervias I., Beal M.F., Manfredi G. Mitochondrial dysfunction and amyotrophic lateral sclerosis. Muscle Nerve. 2006;33:598&#x2013;608.</Citation><ArticleIdList><ArticleId IdType="pubmed">16372325</ArticleId></ArticleIdList></Reference><Reference><Citation>Browne S.E., Beal M.F. Oxidative damage in Huntington's disease pathogenesis. Antioxid. Redox Signal. 2006;8:2061&#x2013;2073.</Citation><ArticleIdList><ArticleId IdType="pubmed">17034350</ArticleId></ArticleIdList></Reference><Reference><Citation>Panov A.V., Gutekunst C.A., Leavitt B.R., Hayden M.R., Burke J.R., Strittmatter W.J., Greenamyre J.T. Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines. Nat. Neurosci. 2002;5:731&#x2013;736.</Citation><ArticleIdList><ArticleId IdType="pubmed">12089530</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Prospero N.A., Fischbeck K.H. Therapeutics development for triplet repeat expansion diseases. Nat. Rev. Genet. 2005;6:756&#x2013;765.</Citation><ArticleIdList><ArticleId IdType="pubmed">16205715</ArticleId></ArticleIdList></Reference><Reference><Citation>Spiegelman B.M. Transcriptional control of energy homeostasis through the PGC1 coactivators. Novartis Found. Symp. 2007;286:3&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">18269170</ArticleId></ArticleIdList></Reference><Reference><Citation>Spiegelman B.M. Transcriptional control of mitochondrial energy metabolism through the PGC1 coactivators. Novartis Found. Symp. 2007;287:60&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">18074631</ArticleId></ArticleIdList></Reference><Reference><Citation>Puigserver P. Tissue-specific regulation of metabolic pathways through the transcriptional coactivator PGC1-alpha. Int. J. Obesity. 2005;29:S5&#x2013;S9.</Citation><ArticleIdList><ArticleId IdType="pubmed">15711583</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Q., Gibson G.E. Oxidative stress and transcriptional regulation in Alzheimer disease. Alz. Dis. Assoc. Disord. 2007;21:276&#x2013;291.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3109432</ArticleId><ArticleId IdType="pubmed">18090434</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z., Puigserver P., Andersson U., Zhang C., Adelmant G., Mootha V., Troy A., Cinti S., Lowell B., Scarpulla R.C., et al. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell. 1999;98:115&#x2013;124.</Citation><ArticleIdList><ArticleId IdType="pubmed">10412986</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui L., Jeong H., Borovecki F., Parkhurst C.N., Tanese N., Krainc D. Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration. Cell. 2006;127:59&#x2013;69.</Citation><ArticleIdList><ArticleId IdType="pubmed">17018277</ArticleId></ArticleIdList></Reference><Reference><Citation>Weydt P., Pineda V.V., Torrence A.E., Libby R.T., Satterfield T.F., Lazarowski E.R., Gilbert M.L., Morton G.J., Bammler T.K., Strand A.D., et al. Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1alpha in Huntington's disease neurodegeneration. Cell Metab. 2006;4:349&#x2013;362.</Citation><ArticleIdList><ArticleId IdType="pubmed">17055784</ArticleId></ArticleIdList></Reference><Reference><Citation>Piccioni F., Pinton P., Simeoni S., Pozzi P., Fascio U., Vismara G., Martini L., Rizzuto R., Poletti A. Androgen receptor with elongated polyglutamine tract forms aggregates that alter axonal trafficking and mitochondrial distribution in motor neuronal processes. FASEB J. 2002;16:1418&#x2013;1420.</Citation><ArticleIdList><ArticleId IdType="pubmed">12205033</ArticleId></ArticleIdList></Reference><Reference><Citation>Beauchemin A.M., Gottlieb B., Beitel L.K., Elhaji Y.A., Pinsky L., Trifiro M.A. Cytochrome c oxidase subunit Vb interacts with human androgen receptor: a potential mechanism for neurotoxicity in spinobulbar muscular atrophy. Brain Res. Bull. 2001;56:285&#x2013;297.</Citation><ArticleIdList><ArticleId IdType="pubmed">11719263</ArticleId></ArticleIdList></Reference><Reference><Citation>Palazzolo I., Burnett B.G., Young J.E., Brenne P.L., La Spada A.R., Fischbeck K.H., Howell B.W., Pennuto M. Akt blocks ligand binding and protects against expanded polyglutamine androgen receptor toxicity. Hum. Mol. Genet. 2007;16:1593&#x2013;1603.</Citation><ArticleIdList><ArticleId IdType="pubmed">17470458</ArticleId></ArticleIdList></Reference><Reference><Citation>Piccioni F., Roman B.R., Fischbeck K.H., Taylor J.P. A screen for drugs that protect against the cytotoxicity of polyglutamine-expanded androgen receptor. Hum. Mol. Genet. 2004;13:437&#x2013;446.</Citation><ArticleIdList><ArticleId IdType="pubmed">14709594</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellerby L.M., Hackam A.S., Propp S.S., Ellerby H.M., Rabizadeh S., Cashman N.R., Trifiro M.A., Pinsky L., Wellington C.L., Salvesen G.S., et al. Kennedy's disease: caspase cleavage of the androgen receptor is a crucial event in cytotoxicity. J. Neurochem. 1999;72:185&#x2013;195.</Citation><ArticleIdList><ArticleId IdType="pubmed">9886069</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi Y., Miwa S., Merry D.E., Kume A., Mei L., Doyu M., Sobue G. Caspase-3 cleaves the expanded androgen receptor protein of spinal and bulbar muscular atrophy in a polyglutamine repeat length-dependent manner. Biochem. Biophys. Res. Commun. 1998;252:145&#x2013;150.</Citation><ArticleIdList><ArticleId IdType="pubmed">9813160</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks B.P., Paulson H.L., Merry D.E., Salazar-Grueso E.F., Brinkmann A.O., Wilson E.M., Fischbeck K.H. Characterization of an expanded glutamine repeat androgen receptor in a neuronal cell culture system. Neurobiol. Dis. 1997;3:313&#x2013;323.</Citation><ArticleIdList><ArticleId IdType="pubmed">9173928</ArticleId></ArticleIdList></Reference><Reference><Citation>Waldmeier P.C., Zimmermann K., Qian T., Tintelnot-Blomley M., Lemasters J.J. Cyclophilin D as a drug target. Curr. Med. Chem. 2003;10:1485&#x2013;1506.</Citation><ArticleIdList><ArticleId IdType="pubmed">12871122</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang T.S., Slow E., Lupu V., Stavrovskaya I.G., Sugimori M., Llinas R., Kristal B.S., Hayden M.R., Bezprozvanny I. Disturbed Ca2+ signaling and apoptosis of medium spiny neurons in Huntington's disease. Proc. Natl Acad. Sci. 2005;102:2602&#x2013;2607.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC548984</ArticleId><ArticleId IdType="pubmed">15695335</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin Z., El-Deiry W.S. Overview of cell death signaling pathways. Cancer Biol. Ther. 2005;4:139&#x2013;163.</Citation><ArticleIdList><ArticleId IdType="pubmed">15725726</ArticleId></ArticleIdList></Reference><Reference><Citation>Masters S.C., Yang H., Datta S.R., Greenberg M.E., Fu H. 14-3-3 inhibits Bad-induced cell death through interaction with serine-136. Mol. Pharmacol. 2001;60:1325&#x2013;1331.</Citation><ArticleIdList><ArticleId IdType="pubmed">11723239</ArticleId></ArticleIdList></Reference><Reference><Citation>Datta S.R., Ranger A.M., Lin M.Z., Sturgill J.F., Ma Y.C., Cowan C.W., Dikkes P., Korsmeyer S.J., Greenberg M.E. Survival factor-mediated BAD phosphorylation raises the mitochondrial threshold for apoptosis. Dev. Cell. 2002;3:631&#x2013;643.</Citation><ArticleIdList><ArticleId IdType="pubmed">12431371</ArticleId></ArticleIdList></Reference><Reference><Citation>Humbert S., Bryson E.A., Cordelieres F.P., Connors N.C., Datta S.R., Finkbeiner S., Greenberg M.E., Saudou F. The IGF-1/Akt pathway is neuroprotective in Huntington's disease and involves Huntingtin phosphorylation by Akt. Dev. Cell. 2002;2:831&#x2013;837.</Citation><ArticleIdList><ArticleId IdType="pubmed">12062094</ArticleId></ArticleIdList></Reference><Reference><Citation>Iijima T. Mitochondrial membrane potential and ischemic neuronal death. Neurosci. Res. 2006;55:234&#x2013;243.</Citation><ArticleIdList><ArticleId IdType="pubmed">16716421</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicholls D.G. Mitochondrial membrane potential and aging. Aging Cell. 2004;3:35&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">14965354</ArticleId></ArticleIdList></Reference><Reference><Citation>Iijima T., Mishima T., Akagawa K., Iwao Y. Mitochondrial hyperpolarization after transient oxygen-glucose deprivation and subsequent apoptosis in cultured rat hippocampal neurons. Brain Res. 2003;993:140&#x2013;145.</Citation><ArticleIdList><ArticleId IdType="pubmed">14642839</ArticleId></ArticleIdList></Reference><Reference><Citation>Fillon S., Lang F., Jendrossek V. Pseudomonas aeruginosa triggered apoptosis of human epithelial cells depends on the temperature during infection. Cell Physiol. Biochem. 2002;12:207&#x2013;214.</Citation><ArticleIdList><ArticleId IdType="pubmed">12297726</ArticleId></ArticleIdList></Reference><Reference><Citation>Adam-Vizi V., Chinopoulos C. Bioenergetics and the formation of mitochondrial reactive oxygen species. Trends Pharmacol. Sci. 2006;27:639&#x2013;645.</Citation><ArticleIdList><ArticleId IdType="pubmed">17056127</ArticleId></ArticleIdList></Reference><Reference><Citation>Brookes P.S. Mitochondrial H(+) leak and ROS generation: an odd couple. Free Radic. Biol. Med. 2005;38:12&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">15589367</ArticleId></ArticleIdList></Reference><Reference><Citation>Butow R.A., Bahassi E.M. Adaptive thermogenesis: orchestrating mitochondrial biogenesis. Curr. Biol. 1999;9:R767&#x2013;R769.</Citation><ArticleIdList><ArticleId IdType="pubmed">10531019</ArticleId></ArticleIdList></Reference><Reference><Citation>Puigserver P., Spiegelman B.M. Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator. Endocr. Rev. 2003;24:78&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">12588810</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin M.T., Beal M.F. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature. 2006;443:787&#x2013;795.</Citation><ArticleIdList><ArticleId IdType="pubmed">17051205</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong J., Xu Z. Massive mitochondrial degeneration in motor neurons triggers the onset of amyotrophic lateral sclerosis in mice expressing a mutant SOD1. J. Neurosci. 1998;18:3241&#x2013;3250.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6792665</ArticleId><ArticleId IdType="pubmed">9547233</ArticleId></ArticleIdList></Reference><Reference><Citation>Lieberman A.P., Harmison G., Strand A.D., Olson J.M., Fischbeck K.H. Altered transcriptional regulation in cells expressing the expanded polyglutamine androgen receptor. Hum. Mol. Genet. 2002;11:1967&#x2013;1976.</Citation><ArticleIdList><ArticleId IdType="pubmed">12165558</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin J., Handschin C., Spiegelman B.M. Metabolic control through the PGC-1 family of transcription coactivators. Cell Metab. 2005;1:361&#x2013;370.</Citation><ArticleIdList><ArticleId IdType="pubmed">16054085</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin J., Wu P.H., Tarr P.T., Lindenberg K.S., St-Pierre J., Zhang C.Y., Mootha V.K., Jager S., Vianna C.R., Reznick R.M., et al. Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1alpha null mice. Cell. 2004;119:121&#x2013;135.</Citation><ArticleIdList><ArticleId IdType="pubmed">15454086</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin J., Tarr P.T., Yang R., Rhee J., Puigserver P., Newgard C.B., Spiegelman B.M. PGC-1beta in the regulation of hepatic glucose and energy metabolism. J. Biol. Chem. 2003;278:30843&#x2013;30848.</Citation><ArticleIdList><ArticleId IdType="pubmed">12807885</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Z., Dadgar N., Albertelli M., Gruis K., Jordan C., Robins D.M., Lieberman A.P. Androgen-dependent pathology demonstrates myopathic contribution to the Kennedy disease phenotype in a mouse knock-in model. J. Clin. Invest. 2006;116:2663&#x2013;2672.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1564432</ArticleId><ArticleId IdType="pubmed">16981011</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Z., Dadgar N., Albertelli M., Scheller A., Albin R.L., Robins D.M., Lieberman A.P. Abnormalities of germ cell maturation and sertoli cell cytoskeleton in androgen receptor 113 CAG knock-in mice reveal toxic effects of the mutant protein. Am. J. Pathol. 2006;168:195&#x2013;204.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1592669</ArticleId><ArticleId IdType="pubmed">16400023</ArticleId></ArticleIdList></Reference><Reference><Citation>Solakidi S., Psarra A.M., Nikolaropoulos S., Sekeris C.E. Estrogen receptors alpha and beta (ERalpha and ERbeta) and androgen receptor (AR) in human sperm: localization of ERbeta and AR in mitochondria of the midpiece. Hum. Reprod. 2005;20:3481&#x2013;3487.</Citation><ArticleIdList><ArticleId IdType="pubmed">16123086</ArticleId></ArticleIdList></Reference><Reference><Citation>Psarra A.M., Bochaton-Piallat M.L., Gabbiani G., Sekeris C.E., Tsacopoulos M. Mitochondrial localization of glucocortocoid receptor in glial (Muller) cells in the salamander retina. Glia. 2003;41:38&#x2013;49.</Citation><ArticleIdList><ArticleId IdType="pubmed">12465044</ArticleId></ArticleIdList></Reference><Reference><Citation>Psarra A.M., Sekeris C.E. Steroid and thyroid hormone receptors in mitochondria. IUBMB life. 2008;60:210&#x2013;223.</Citation><ArticleIdList><ArticleId IdType="pubmed">18344181</ArticleId></ArticleIdList></Reference><Reference><Citation>Demonacos C., Tsawdaroglou N.C., Djordjevic-Markovic R., Papalopoulou M., Galanopoulos V., Papadogeorgaki S., Sekeris C.E. Import of the glucocorticoid receptor into rat liver mitochondria in vivo and in vitro. J. Steroid. Biochem. Mol. Biol. 1993;46:401&#x2013;413.</Citation><ArticleIdList><ArticleId IdType="pubmed">9831490</ArticleId></ArticleIdList></Reference><Reference><Citation>Psarra A.M., Solakidi S., Sekeris C.E. The mitochondrion as a primary site of action of regulatory agents involved in neuroimmunomodulation. Ann. NY Acad. Sci. 2006;1088:12&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">17192553</ArticleId></ArticleIdList></Reference><Reference><Citation>Pozzi C., Valtorta M., Tedeschi G., Galbusera E., Pastori V., Bigi A., Nonnis S., Grassi E., Fusi P. Study of subcellular localization and proteolysis of ataxin-3. Neurobiol. Dis. 2008;30:190&#x2013;200.</Citation><ArticleIdList><ArticleId IdType="pubmed">18353661</ArticleId></ArticleIdList></Reference><Reference><Citation>Berman S.B., Watkins S.C., Hastings T.G. Quantitative biochemical and ultrastructural comparison of mitochondrial permeability transition in isolated brain and liver mitochondria: evidence for reduced sensitivity of brain mitochondria. Exp. Neurol. 2000;164:415&#x2013;425.</Citation><ArticleIdList><ArticleId IdType="pubmed">10915580</ArticleId></ArticleIdList></Reference><Reference><Citation>Brocard J.B., Rintoul G.L., Reynolds I.J. New perspectives on mitochondrial morphology in cell function. Biol. Cell. 2003;95:239&#x2013;242.</Citation><ArticleIdList><ArticleId IdType="pubmed">12941521</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang D.T., Reynolds I.J. Differences in mitochondrial movement and morphology in young and mature primary cortical neurons in culture. Neuroscience. 2006;141:727&#x2013;736.</Citation><ArticleIdList><ArticleId IdType="pubmed">16797853</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho S., Clipstone N., Timmermann L., Northrop J., Graef I., Fiorentino D., Nourse J., Crabtree G.R. The mechanism of action of cyclosporin A and FK506. Clin. Immunol. Immunopathol. 1996;80:S40&#x2013;S45.</Citation><ArticleIdList><ArticleId IdType="pubmed">8811062</ArticleId></ArticleIdList></Reference><Reference><Citation>Dineley K.E., Richards L.L., Votyakova T.V., Reynolds I.J. Zinc causes loss of membrane potential and elevates reactive oxygen species in rat brain mitochondria. Mitochondrion. 2005;5:55&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pubmed">16060292</ArticleId></ArticleIdList></Reference><Reference><Citation>Melov S., Schneider J.A., Day B.J., Hinerfeld D., Coskun P., Mirra S.S., Crapo J.D., Wallace D.C. A novel neurological phenotype in mice lacking mitochondrial manganese superoxide dismutase. Nat. Genet. 1998;18:159&#x2013;163.</Citation><ArticleIdList><ArticleId IdType="pubmed">9462746</ArticleId></ArticleIdList></Reference><Reference><Citation>Esposito L., Raber J., Kekonius L., Yan F., Yu G.Q., Bien-Ly N., Puolivali J., Scearce-Levie K., Masliah E., Mucke L. Reduction in mitochondrial superoxide dismutase modulates Alzheimer's disease-like pathology and accelerates the onset of behavioral changes in human amyloid precursor protein transgenic mice. J. Neurosci. 2006;26:5167&#x2013;5179.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6674260</ArticleId><ArticleId IdType="pubmed">16687508</ArticleId></ArticleIdList></Reference><Reference><Citation>Bitzer M., Armeanu S., Prinz F., Ungerechts G., Wybranietz W., Spiegel M., Bernlohr C., Cecconi F., Gregor M., Neubert W.J., et al. Caspase-8 and Apaf-1-independent caspase-9 activation in Sendai virus-infected cells. J. Biol. Chem. 2002;277:29817&#x2013;29824.</Citation><ArticleIdList><ArticleId IdType="pubmed">12021264</ArticleId></ArticleIdList></Reference><Reference><Citation>Gyrd-Hansen M., Farkas T., Fehrenbacher N., Bastholm L., Hoyer-Hansen M., Elling F., Wallach D., Flavell R., Kroemer G., Nylandsted J., et al. Apoptosome-independent activation of the lysosomal cell death pathway by caspase-9. Mol. Cell Biol. 2006;26:7880&#x2013;7891.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1636747</ArticleId><ArticleId IdType="pubmed">16966373</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho A.T., Li Q.H., Hakem R., Mak T.W., Zacksenhaus E. Coupling of caspase-9 to Apaf1 in response to loss of pRb or cytotoxic drugs is cell-type-specific. EMBO J. 2004;23:460&#x2013;472.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1271749</ArticleId><ArticleId IdType="pubmed">14713951</ArticleId></ArticleIdList></Reference><Reference><Citation>Morishima N., Nakanishi K., Takenouchi H., Shibata T., Yasuhiko Y. An endoplasmic reticulum stress-specific caspase cascade in apoptosis. Cytochrome c-independent activation of caspase-9 by caspase-12. J. Biol. Chem. 2002;277:34287&#x2013;34294.</Citation><ArticleIdList><ArticleId IdType="pubmed">12097332</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim G.J., Fiskum G.M., Morgan W.F. A role for mitochondrial dysfunction in perpetuating radiation-induced genomic instability. Cancer Res. 2006;66:10377&#x2013;10383.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2570498</ArticleId><ArticleId IdType="pubmed">17079457</ArticleId></ArticleIdList></Reference><Reference><Citation>Panduri V., Weitzman S.A., Chandel N.S., Kamp D.W. Mitochondrial-derived free radicals mediate asbestos-induced alveolar epithelial cell apoptosis. Am. J. Physiol. 2004;286:L1220&#x2013;L1227.</Citation><ArticleIdList><ArticleId IdType="pubmed">14766669</ArticleId></ArticleIdList></Reference><Reference><Citation>Avila A.M., Burnett B.G., Taye A.A., Gabanella F., Knight M.A., Hartenstein P., Cizman Z., Di Prospero N.A., Pellizzoni L., Fischbeck K.H., et al. Trichostatin A increases SMN expression and survival in a mouse model of spinal muscular atrophy. J. Clin. Invest. 2007;117:659&#x2013;671.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1797603</ArticleId><ArticleId IdType="pubmed">17318264</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfaffl M.W. A new mathematical model for relative quantification in real-time RT&#x2013;PCR. Nucleic Acids Res. 2001;29:e45.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC55695</ArticleId><ArticleId IdType="pubmed">11328886</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanner V.A., Ploug T., Tao-Cheng J.H. Subcellular localization of SV2 and other secretory vesicle components in PC12 cells by an efficient method of preembedding EM immunocytochemistry for cell cultures. J. Histochem. Cytochem. 1996;44:1481&#x2013;1488.</Citation><ArticleIdList><ArticleId IdType="pubmed">8985140</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J., Lillo C., Jonsson P.A., Vande Velde C., Ward C.M., Miller T.M., Subramaniam J.R., Rothstein J.D., Marklund S., Andersen P.M., et al. Toxicity of familial ALS-linked SOD1 mutants from selective recruitment to spinal mitochondria. Neuron. 2004;43:5&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pubmed">15233913</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy J.R., Sumner C.J., Caviston J.P., Tokito M.K., Ranganathan S., Ligon L.A., Wallace K.E., LaMonte B.H., Harmison G.G., Puls I., et al. A motor neuron disease-associated mutation in p150Glued perturbs dynactin function and induces protein aggregation. J. Cell Biol. 2006;172:733&#x2013;745.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2063705</ArticleId><ArticleId IdType="pubmed">16505168</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>